DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Statistics

Total Valuation

DOD Biotech PCL has a market cap or net worth of THB 815.25 million. The enterprise value is 751.88 million.

Market Cap	815.25M
Enterprise Value	751.88M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	Mar 13, 2026

Share Statistics

DOD Biotech PCL has 450.41 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	450.41M
Shares Outstanding	450.41M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	32.20%
Owned by Institutions (%)	19.52%
Float	261.26M

Valuation Ratios

The trailing PE ratio is 17.31.

PE Ratio	17.31
Forward PE	n/a
PS Ratio	1.31
PB Ratio	0.85
P/TBV Ratio	0.89
P/FCF Ratio	19.21
P/OCF Ratio	8.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.61, with an EV/FCF ratio of 17.72.

EV / Earnings	12.62
EV / Sales	1.21
EV / EBITDA	8.61
EV / EBIT	16.97
EV / FCF	17.72

Financial Position

The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.07.

Current Ratio	4.28
Quick Ratio	1.73
Debt / Equity	0.07
Debt / EBITDA	0.81
Debt / FCF	1.66
Interest Coverage	15.47

Financial Efficiency

Return on equity (ROE) is 5.43% and return on invested capital (ROIC) is 4.25%.

Return on Equity (ROE)	5.43%
Return on Assets (ROA)	2.27%
Return on Invested Capital (ROIC)	4.25%
Return on Capital Employed (ROCE)	4.27%
Weighted Average Cost of Capital (WACC)	8.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	65
Asset Turnover	0.51
Inventory Turnover	3.34

Taxes

Income Tax	-6.65M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.41% in the last 52 weeks. The beta is 0.80, so DOD Biotech PCL's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+41.41%
50-Day Moving Average	1.65
200-Day Moving Average	1.77
Relative Strength Index (RSI)	53.39
Average Volume (20 Days)	5,724,661

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DOD Biotech PCL had revenue of THB 621.21 million and earned 59.59 million in profits. Earnings per share was 0.13.

Revenue	621.21M
Gross Profit	222.30M
Operating Income	44.30M
Pretax Income	43.45M
Net Income	59.59M
EBITDA	87.30M
EBIT	44.30M
Earnings Per Share (EPS)	0.13

Balance Sheet

The company has 129.23 million in cash and 70.35 million in debt, with a net cash position of 58.88 million or 0.13 per share.

Cash & Cash Equivalents	129.23M
Total Debt	70.35M
Net Cash	58.88M
Net Cash Per Share	0.13
Equity (Book Value)	953.84M
Book Value Per Share	2.13
Working Capital	381.14M

Cash Flow

In the last 12 months, operating cash flow was 91.31 million and capital expenditures -48.88 million, giving a free cash flow of 42.43 million.

Operating Cash Flow	91.31M
Capital Expenditures	-48.88M
Free Cash Flow	42.43M
FCF Per Share	0.09

Margins

Gross margin is 35.78%, with operating and profit margins of 7.13% and 9.59%.

Gross Margin	35.78%
Operating Margin	7.13%
Pretax Margin	6.99%
Profit Margin	9.59%
EBITDA Margin	14.05%
EBIT Margin	7.13%
FCF Margin	6.83%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.48%.

Dividend Per Share	0.05
Dividend Yield	2.48%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	2.48%
Earnings Yield	7.31%
FCF Yield	5.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5